CUV 1.42% $13.90 clinuvel pharmaceuticals limited

THE CLINUVEL SHARE BUYBACK, page-112

  1. 166 Posts.
    lightbulb Created with Sketch. 55
    It’s worse than embarrassing, it’s literally costing shareholders millions.

    EPP patients and shareholders alike have been failed, primarily by out of date and partially fraudulent authoritys in bed with big suncream pharma , with the scheming lackadaisical wolgen doing nothing much over 2 decades to progress this important (stigmatised by morons!) skin preserving drug or to rectify the foolish “no such thing as a safe tan narrative”.

    The drug is incredible but all the leaches that have attached themselves are shameless and need to be salted!
    Last edited by Melon felon!: 26/09/24
 
watchlist Created with Sketch. Add CUV (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.